TB Alternative Assets Ltd. Makes New $10.18 Million Investment in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

TB Alternative Assets Ltd. purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report) during the first quarter, Holdings Channel reports. The fund purchased 76,700 shares of the company’s stock, valued at approximately $10,180,000. Direxion Daily S&P Biotech Bull 3x Shares makes up about 2.5% of TB Alternative Assets Ltd.’s holdings, making the stock its 12th largest position.

A number of other hedge funds and other institutional investors also recently made changes to their positions in LABU. Tower Research Capital LLC TRC boosted its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 49,146.3% in the 3rd quarter. Tower Research Capital LLC TRC now owns 352,111 shares of the company’s stock worth $1,342,000 after buying an additional 351,396 shares during the last quarter. Traynor Capital Management Inc. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter worth about $325,000. Gateway Advisory LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter valued at about $366,000. Jump Financial LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter valued at about $521,000. Finally, Sheaff Brock Investment Advisors LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter valued at about $488,000.

Direxion Daily S&P Biotech Bull 3x Shares Trading Down 3.1 %

Direxion Daily S&P Biotech Bull 3x Shares stock traded down $3.59 during midday trading on Wednesday, reaching $111.84. The stock had a trading volume of 1,219,860 shares, compared to its average volume of 2,587,950. Direxion Daily S&P Biotech Bull 3x Shares has a 12 month low of $48.40 and a 12 month high of $176.99. The firm’s 50-day moving average price is $105.41 and its 200 day moving average price is $117.91.

Direxion Daily S&P Biotech Bull 3x Shares Company Profile

(Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Read More

Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report).

Institutional Ownership by Quarter for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.